Indaba Capital Management, L.P.
CIK 1524362 · Holdings on Dec 31, 2024 · First reported Feb 14, 2025
Top ten holdings
Q4 2024- 69122G10219.41%
- 05988JAD515.50%
- ONTF13.20%
- 761330AB511.58%
- 866082AA810.58%
- 2946281028.14%
- 46333XAH16.28%
- 761299AB26.18%
- 00430HAC65.95%
- 29664W1053.18%
Share classes counted separately100.00%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- 294628102Weight decreased · -31.88 pp40.02% → 8.14%Shares +4.85M (+103.19%)
- 866082AA8Weight increased · +8.76 pp1.82% → 10.58%Shares +18.16M (+403.64%)
- 46333XAH1Weight increased · +2.87 pp3.41% → 6.28%Shares +5.00M (+55.56%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 10
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | 69122G102BLUE OWL CAP CORP IIICOM SHS View history and evidence | $40.28M | 19.41% | 2.79M shares | Prior unavailable +2.79M | New | ↗▾ |
| 02 | 05988JAD5BANDWIDTH INCNOTE 0.500% 4/0 View history and evidence | $32.17M | 15.50% | 40.25M principal (USD) | 13.44% → 15.50%+2.06 pp 0 (0.00%) | Unchanged | ↗▾ |
| 03 | ONTFON24 INC View history and evidence | $27.39M | 13.20% | 4.24M shares | 11.10% → 13.20%+2.10 pp 0 (0.00%) | Unchanged | ↗▾ |
| 04 | 761330AB5REVANCE THERAPEUTICS INCNOTE 1.750% 2/1 View history and evidence | $24.03M | 11.58% | 25.00M principal (USD) | Prior unavailable +25.00M | New | ↗▾ |
| 05 | 866082AA8SUMMIT HOTEL PROPERTIESNOTE 1.500% 2/1 View history and evidence | $21.97M | 10.58% | 22.66M principal (USD) | 1.82% → 10.58%+8.76 pp +18.16M (+403.64%) | Added | ↗▾ |
| 06 | 294628102EQUITY COMMONWEALTHCOM SH BEN INT View history and evidence | $16.90M | 8.14% | 9.55M shares | 40.02% → 8.14%-31.88 pp +4.85M (+103.19%) | Added | ↗▾ |
| 07 | 46333XAH1IRONWOOD PHARMACEUTICALSNOTE 1.500% 6/1 View history and evidence | $13.04M | 6.28% | 14.00M principal (USD) | 3.41% → 6.28%+2.87 pp +5.00M (+55.56%) | Added | ↗▾ |
| 08 | 761299AB2TRAVERE THERAPEUTICS INCNOTE 2.500% 9/1 View history and evidence | $12.83M | 6.18% | 13.00M principal (USD) | Prior unavailable +13.00M | New | ↗▾ |
| 09 | 00430HAC6ACCELERATE DIAGNOSTICSNOTE 5.000%12/1 View history and evidence | $12.34M | 5.95% | 24.69M principal (USD) | 5.31% → 5.95%+0.64 pp +602.10K (+2.50%) | Added | ↗▾ |
| 10 | 29664W105ESPERION THERAPEUTICS INC NE View history and evidence | $6.60M | 3.18% | 3.00M shares | Prior unavailable +3.00M | New | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 3
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| 29664WAB1 ESPERION THERAPEUTICS | Non-derivative | -33,750,000 | -$32.02M | SEC filing ↗ | SEC filing ↗ |
| 98423FAB5 XOMETRY INC | Non-derivative | -21,750,000 | -$18.55M | SEC filing ↗ | SEC filing ↗ |
| 34385PAF5 STANDARD BIOTOOLS INC | Non-derivative | -7,660,000 | -$7.63M | SEC filing ↗ | SEC filing ↗ |
3 / 3 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1524362 · Period 2024-12-31
Data loaded 2026-09-23 · First reported 2025-02-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 207547740
}Take these holdings further.
This page includes 10 of 10 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 10 of 10 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1524362","quarter":"2024Q4","page_size":100}
get_institutional_manager_history
{"cik":"1524362","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.